Devendra D, Galloway T S, Horton S J, Evenden A, Keller U, Wilkin T J
Department of University Medicine, Plymouth Campus, United Kingdom.
Diabetologia. 2003 Jun;46(6):802-9. doi: 10.1007/s00125-003-1107-7. Epub 2003 Jun 3.
AIM/HYPOTHESIS: Radiobinding assays (RBA) are unable to differentiate insulin autoantibodies (IAA) from insulin antibodies (IA). We sought to establish whether random peptide phage display might generate reagents with which to distinguish IAA idiotopes from IA idiotopes.
Two insulin-binding sera were used to select phagotopes from a phage library. The first, designated IAS, came from an insulin-treated patient with the insulin autoimmune syndrome, and was known to contain both IA and a high titre of human insulin specific (B30 threonine dependent) IAA. The second, designated IDD, was taken from a newly-diagnosed IAA(+) Type 1 diabetic patient. Phage colonies selected by insulin-purified IgG extracts of IAS and IDD were selected at random for DNA sequencing, and tested for their reactivity with insulin antibodies and ability to distinguish disease-associated idiotopes.
Seven phagotopes bound IAS and the phagotope designated IAS-9, corresponding to sequence KRSRLDV, gave the highest binding standard deviation (SD) score. Seven phagotopes bound IDD and the phagotope designated IDD-10, corresponding to sequence LGRGGSK, bound most strongly. IAS-9 was able to displace insulin binding in IAS and all of ten insulin-treated Type 2 diabetic patients, but not the IAA present in any of the eight patients with newly-diagnosed Type 1 diabetes. IDD-10, on the other hand, could displace insulin binding detected in the sera of eight patients with untreated Type 1 diabetes (IAA), but not in IAS or sera of the insulin-treated Type 2 diabetics.
Phagotopes provide reagents which between them can distinguish positively as well as negatively diabetes-associated IAA from non-diabetes associated IAA and from IA.
目的/假设:放射结合分析(RBA)无法区分胰岛素自身抗体(IAA)和胰岛素抗体(IA)。我们试图确定随机肽噬菌体展示是否能产生用于区分IAA独特型与IA独特型的试剂。
使用两份胰岛素结合血清从噬菌体文库中筛选噬菌体位点。第一份血清命名为IAS,来自一名接受胰岛素治疗的胰岛素自身免疫综合征患者,已知其同时含有IA和高滴度的人胰岛素特异性(B30苏氨酸依赖性)IAA。第二份血清命名为IDD,取自一名新诊断的IAA(+)1型糖尿病患者。随机选择由IAS和IDD的胰岛素纯化IgG提取物筛选出的噬菌体菌落进行DNA测序,并检测它们与胰岛素抗体的反应性以及区分疾病相关独特型的能力。
七个噬菌体位点与IAS结合,命名为IAS-9的噬菌体位点(对应序列KRSRLDV)给出了最高的结合标准差(SD)分数。七个噬菌体位点与IDD结合,命名为IDD-10的噬菌体位点(对应序列LGRGGSK)结合最强。IAS-9能够取代IAS以及十名接受胰岛素治疗的2型糖尿病患者血清中的胰岛素结合,但不能取代八名新诊断的1型糖尿病患者血清中存在的IAA。另一方面,IDD-10能够取代八名未经治疗的1型糖尿病患者(IAA)血清中检测到的胰岛素结合,但不能取代IAS或接受胰岛素治疗的2型糖尿病患者血清中的胰岛素结合。
噬菌体位点提供的试剂能够区分与糖尿病相关的IAA和与非糖尿病相关的IAA以及IA,无论是阳性还是阴性。